Awarded contract

Lanadelumab Injection - Shire

  • BELFAST HEALTH AND SOCIAL CARE TRUST

F03: Contract award notice

Notice reference: 2021/S 000-002925

Published 12 February 2021, 3:09pm



Section one: Contracting authority

one.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

Contact

Norma Moore

Email

norma.moore@belfasttrust.hscni.net

Country

United Kingdom

NUTS code

UKN - NORTHERN IRELAND

Internet address(es)

Main address

www.belfasttrust.hscni.net

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Lanadelumab Injection - Shire

Reference number

DACPM2021-04

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Lanadelumab Injection - Shire

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £300,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKN - NORTHERN IRELAND

two.2.4) Description of the procurement

Lanadelumab Injection - Shire

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • protection of exclusive rights, including intellectual property rights

Explanation:

This is a branded patent protected medicine for the treatment of hereditary angioedema which is only available from Shire Pharmaceuticals

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

DACPM2021-04

Title

Lanadelumab Injection - Shire

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

3 February 2021

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Shire Pharmaceuticals (part of Takeda Pharmaceutical Company)

1 Kingdom Street

London

W2 6BD

Country

United Kingdom

NUTS code
  • UKI - LONDON
Internet address

https://www.takeda.com/en-gb/

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £300,000

Total value of the contract/lot: £300,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Belfast Health & Social Care Trust

Lisburn Road

Belfast

BT9 7AB

Country

United Kingdom